Business Context and Reporting Period
Rigetti Computing, Inc. (RGTI), an emerging growth company, filed a Form 8-K on February 27, 2025, reporting the entry into a strategic partnership with Quanta Computer Inc. The filing details a five-year Collaboration Agreement and a concurrent Securities Purchase Agreement aimed at advancing Rigetti's quantum computing product roadmap.
Key Financial Metrics and Transaction Details
- Capital Raise: Rigetti agreed to sell 3,020,412 shares of common stock to Quanta in a private placement for an aggregate value of approximately $35,000,000 at a price of $11.58782 per share.
- Investment Commitments: Both Rigetti and Quanta have committed to invest at least $250,000,000 each over the five-year term of the Collaboration Agreement. Rigetti's investment will further its product roadmap, while Quanta's will fund personnel, capital expenditures, and manufacturing capabilities for Rigetti's products.
- Supply Pricing: Covered Components (excluding dilution refrigerators) will be priced at Quanta's direct material and manufacturing costs plus an agreed-upon percentage. Dilution refrigerators will be priced competitively.
- Liquidity and Debt: The filing does not provide current cash balance, debt levels, or operating margin data. The $35 million raise is subject to closing conditions.
Material Changes and Agreements
The primary material change is the establishment of a strategic supply and development relationship with Quanta Computer Inc. Key terms include:
- Collaboration Scope: Quanta will develop "Covered Components" (control systems, dilution refrigerators, flexible cables, and other non-QPU components) based on future statements of work.
- Intellectual Property: Rigetti retains all rights to QPU Technology created under the agreement. Jointly created technology will be owned equally (50/50) by both parties.
- Exclusivity: Quanta agreed to supply Covered Components developed under the agreement solely to Rigetti, though Quanta retains rights to supply other non-covered products to third parties.
- Board Observer Rights: Quanta will have the right to appoint a non-voting observer to Rigetti's board of directors until the Collaboration Agreement is terminated.
Guidance, Risks, and Contingencies
The transaction is subject to several material contingencies and risks:
- Regulatory Clearance: Closing of the private placement is contingent upon the expiration of a 30-day waiting period following a classification request to the Bureau of Industry and Security (BIS). If BIS Clearance is not obtained by December 31, 2025, either party may terminate the agreements.
- Performance Milestones: The Collaboration Agreement may be terminated if no statement of work is entered into by December 31, 2025.
- Lock-Up Period: Quanta is prohibited from selling the acquired shares for three years following the closing date.
- Forward-Looking Statements: Management expects the agreements to provide significant benefits, but actual results may differ due to regulatory delays, failure to meet milestones, or market conditions.
Investor Verification Checklist
- Verify the status of the BIS Clearance request and the expected timeline for the 30-day waiting period to expire.
- Confirm the exact closing date of the $35 million private placement and the issuance of shares.
- Review the specific "agreed upon additional percentage" for component pricing in the full Collaboration Agreement (Exhibit 10.1).
- Monitor for the execution of the first "statement of work" to ensure the partnership moves beyond the framework stage before the December 31, 2025 deadline.
- Assess the impact of the 3-year lock-up on Quanta's ability to exit the investment and potential future liquidity for Rigetti.